Study shows that mitochondrial-targeted sulfide
Author: Michael
Vitalia CEO Niklas Anzinger on creating lasting
Startup secures $5.
Announced merger aims to foster collaboration an
New research shows that stochastic variation alo
Delivering siRNA therapies to the kidney could p
A novel peptide could provide a more targeted ap
Scott Fulton explores how emerging technologies
Oura Ring 4 tracks new signals to improve accura
The Cat Health Company aims to develop cutting-e